Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 10:39 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2497–2520 of 3,983 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Cerebellar Diseases
Interventions: Testing of emotional communication ability, magnetic resonance imaging (MRI) of the brain; Behavioral · Procedure
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 90 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Food Insecurity
Interventions: Food Security Screening & Referral Program; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 5 Years and older
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: La Jolla, California • San Diego, California

Conditions: Inspiratory Strength Training (IST), Transcutaneous Spinal Stimulation, Sham Spinal Stimulation
Interventions: Spinal cord stimulation, Inspiratory Strength Training, Sham Stimulation; Device · Behavioral · Other
Lead sponsor: University of Florida; Other
Eligibility: 25 Years to 80 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Mobility Limitation, Cognitive Impairment
Interventions: Task-oriented resistance exercise; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 65 Years to 90 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 2
States / cities: Gainesville, Florida

Conditions: Urinary Bladder, Neurogenic
Interventions: Connected Catheter; Device
Lead sponsor: Spinal Singularity; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 2
States / cities: Downey, California • Murrieta, California

Conditions: Mild Cognitive Impairment, Alzheimer Dementia (AD)
Interventions: Closed-loop TBS, Open-loop TBS; Device
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 90 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Fall, Mild Cognitive Impairment (MCI), Aging
Interventions: Digital STEADI-1, STEADI Standard of Care, Digital STEADI-2, Attentional control; Behavioral
Lead sponsor: Friendi.fi Corporation; Industry
Eligibility: 50 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Colorectal Cancer
Interventions: REDCap Questionnaires; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older · Female only
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Septic Shock
Interventions: Mild Induced Hypothermia; Procedure
Lead sponsor: Danish Procalcitonin Study Group; Other
Eligibility: 50 Years to 120 Years
Enrollment: 433 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Mild Cognitive Impairment
Interventions: Active frontal, Active parietal, Sham; Device
Lead sponsor: The University of Texas at Dallas; Other
Eligibility: 40 Years to 90 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Richardson, Texas

Conditions: Cataract Surgery, Cognitive Impairment
Interventions: Remimazolam, Midazolam; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 65 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Mild Cognitive Impairment
Interventions: CX516, Placebo; Drug
Lead sponsor: RespireRx; Industry
Eligibility: 55 Years to 85 Years
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2004
U.S. locations: 8
States / cities: Peoria, Arizona • Irvine, California • Los Angeles, California + 5 more

Conditions: Chagas Cardiomyopathy, Cardiac Arrhythmia, Stroke, Left Ventricular Function Systolic Dysfunction, Cardiac Death
Interventions: Not listed
Lead sponsor: Universidade Gama Filho; Other
Eligibility: 18 Years to 75 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1995 – 2012
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Mild Cognitive Impairment, Obesity
Interventions: Time restricted eating; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 65 Years to 85 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Postoperative Delirium, Postoperative Cognitive Dysfunction, Mild Cognitive Impairment
Interventions: Dextrose Water, Caffeine citrate; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 70 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: ME/CFS, Long COVID, PASC
Interventions: Pyridostigmine, Low-Dose Naltrexone, Placebo; Drug · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: IFN-Gamma Therapy, CGD Gene Mutation, CGD Response to IFNg, CGD - Chronic Granulomatous Disease, Immunodeficiency Disease
Interventions: IFN-gamma; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: Not listed
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Erectile Dysfunction
Interventions: Animal based diet, Plant based diet; Other
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years to 35 Years · Male only
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Hereditary Hemochromatosis
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 21 Years to 100 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Preclinical Alzheimer's Disease
Interventions: Gemfibrozil, Placebo; Drug
Lead sponsor: Gregory Jicha, 323-5550; Other
Eligibility: 65 Years to 90 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: CTE, TBI (Traumatic Brain Injury)
Interventions: [F-18]FDDNP; Radiation
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 90 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: General; Metabolic Disorder, Sexual Dysfunction, Hair Loss, Pathology
Interventions: Not listed
Lead sponsor: Roman Health Ventures Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 10,000 participants
Timeline: 2023 – 2033
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Compensated Liver Cirrhosis, Metabolic Dysfunction Associated Steatohepatitis (MASH)
Interventions: BI 770371, Placebo for BI 770371; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 13
States / cities: Chandler, Arizona • Coronado, California • Montclair, California + 8 more

Conditions: Sepsis
Interventions: Bilateral phrenic nerve stimulation and measurement of transdiaphragmatic pressure, Midazolam, Volitional Measurement of Maximal Inspiratory Pressure (MIP), Inspiratory Muscle Strength Training (IMST), SHAM Inspiratory Muscle Strength Training (IMST), Diaphragm thickness measurement, Blood and Urine samples; Procedure · Drug · Device + 1 more
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Gainesville, Florida

Search by objective public record fields.

Emotional Communication Disorders in Cerebellar Disease

Implementing Food Referrals for Equity and Sustained Health

Rehab and Mechanical Ventilation

Living Independence Through Functional Training

Connected Catheter Clinical Feasibility Study( CFS)

Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline

Digital STEADI Efficacy

Radiation Therapy on Pelvic Floor Disorders in Women

The Cooling And Surviving Septic Shock Study (CASS)

Investigating HD-tDCS in Improving Word Finding and Memory Retrieval in Individuals With MCI

Remimazolam for Cataract Surgery

Efficacy And Safety Of CX516 In Elderly Participants With Mild Cognitive Impairment.

The Signal-averaged ElectrocArdiogram in Long Term Follow-up of Chronic CHagas Disease - RIO de Janeiro Cohort

Time Restricted Eating for Metabolic and Psychological Optimization

The Caffeine, Postoperative Delirium, and Change in Outcomes After Surgery (CAPACHINOS-2) Study

LIFT: Life Improvement Trial

Biochemical Response to Interferon-Gamma in Subjects With Specific Gene Mutation in Chronic Granulomatous Disease

The Impact of Dietary Pattern on Erectile Function

Cardiac Function in Patients With Hereditary Hemochromatosis

Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease

Traumatic Brain Injury and Risk for Chronic Traumatic Encephalopathy

Blood Specimen Collection For Laboratory Assay Research

A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH

Project 4A: Inspiratory Muscle Training and Diaphragm Strength